Total Payments
$1,750
2024 Payments
$52.94
Companies
21
Transactions
76
Medicare Patients
1,111
Medicare Billing
$154,583
Payment Breakdown by Category
Food & Beverage$1,750 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,750 | 76 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $306.28 | 4 | $0 (2020) |
| Amgen Inc. | $274.13 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $257.43 | 11 | $0 (2022) |
| PFIZER INC. | $217.51 | 9 | $0 (2023) |
| ABBVIE INC. | $152.99 | 12 | $0 (2024) |
| Allergan Inc. | $147.91 | 10 | $0 (2019) |
| Almatica Pharma LLC | $64.03 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.72 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.94 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $34.39 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.94 | 3 | ABBVIE INC. ($20.02) |
| 2023 | $77.97 | 4 | Exact Sciences Corporation ($24.49) |
| 2022 | $175.82 | 5 | AstraZeneca Pharmaceuticals LP ($131.62) |
| 2021 | $358.51 | 20 | AbbVie Inc. ($110.62) |
| 2020 | $328.79 | 11 | PFIZER INC. ($173.13) |
| 2019 | $378.64 | 8 | Amarin Pharma Inc. ($194.31) |
| 2018 | $219.65 | 14 | Amgen Inc. ($59.65) |
| 2017 | $157.48 | 11 | Allergan Inc. ($93.10) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Opioid Analgesic | ||||||
| 12/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Oncology | ||||||
| 11/15/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: PAIN | ||||||
| 07/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Gastroenterology | ||||||
| 12/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Diabetes | ||||||
| 04/07/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.22 | General |
| Category: Respiratory | ||||||
| 04/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Respiratory | ||||||
| 01/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Gastroenterology | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Gastroenterology | ||||||
| 11/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 07/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2021 | Almatica Pharma LLC | GRALISE (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 06/10/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $95.02 | General |
| Category: Cardiology | ||||||
| 05/12/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ANALGESIC | ||||||
| 05/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: ANALGESIC | ||||||
| 04/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: GASTROINTESTINAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 196 | 680 | $111,172 | $32,728 |
| 2022 | 5 | 249 | 757 | $126,663 | $33,460 |
| 2021 | 6 | 321 | 1,247 | $175,311 | $46,867 |
| 2020 | 4 | 345 | 1,300 | $166,749 | $41,529 |
Total Patients
1,111
Total Services
3,984
Medicare Billing
$154,583
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 263 | $60,335 | $13,597 | 22.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 51 | 313 | $15,650 | $11,549 | 73.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 104 | $35,187 | $7,582 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 254 | $58,270 | $13,172 | 22.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 39 | 234 | $11,700 | $8,609 | 73.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 125 | $42,293 | $8,437 | 19.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 12 | 84 | $8,400 | $1,821 | 21.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 12 | 60 | $6,000 | $1,421 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 314 | $72,035 | $15,854 | 22.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 56 | 471 | $23,550 | $11,371 | 48.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 135 | $45,676 | $9,839 | 21.5% |
| 99458 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; each additional 20 minute | Office | 2021 | 16 | 183 | $18,300 | $4,746 | 25.9% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 20 | 117 | $11,700 | $3,457 | 29.5% |
| 99491 | Chronic care management services by qualified health care professional, 30 minutes or more per calendar month | Office | 2021 | 14 | 27 | $4,050 | $1,600 | 39.5% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 86 | 745 | $37,250 | $19,585 | 52.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 165 | 450 | $103,235 | $16,749 | 16.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 71 | $23,913 | $4,701 | 19.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 26 | 34 | $2,351 | $494.08 | 21.0% |
About Dr. Steven Corse, DO
Dr. Steven Corse, DO is a Family Medicine healthcare provider based in Highland, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750356978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Corse, DO has received a total of $1,750 in payments from pharmaceutical and medical device companies, with $52.94 received in 2024. These payments were reported across 76 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,750).
As a Medicare-enrolled provider, Corse has provided services to 1,111 Medicare beneficiaries, totaling 3,984 services with total Medicare billing of $154,583. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Highland, IN
- Active Since 02/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750356978
Products in Payments
- Vascepa (Drug) $306.28
- Repatha (Biological) $274.13
- BREZTRI (Drug) $131.62
- ELIQUIS (Drug) $104.01
- VRAYLAR (Drug) $99.78
- UBRELVY (Drug) $80.75
- FARXIGA (Drug) $65.60
- JARDIANCE (Drug) $55.72
- LINZESS (Drug) $50.14
- NAPRELAN (Drug) $48.48
- MOVANTIK (Drug) $44.08
- BYSTOLIC (Drug) $39.54
- CHANTIX (Drug) $37.59
- XIFAXAN (Drug) $31.24
- VIBERZI (Drug) $30.69
- FLECTOR (Drug) $26.81
- Symproic (Drug) $25.54
- RELISTOR (Drug) $25.53
- Cologuard Collection Kit (Device) $24.49
- Morphabond ER (Drug) $23.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Highland
Ravneet Singh, M.d, M.D
Family Medicine — Payments: $44,671
Family Medicine $44,671
Hao Thai, Md, MD
Family Medicine — Payments: $17,943
Family Medicine $17,943
Carolina Ocampo, M.d, M.D
Family Medicine — Payments: $13,855
Family Medicine $13,855
Dr. Raghad Lepley, Md, MD
Family Medicine — Payments: $13,367
Family Medicine $13,367
Lloyd Costello, M.d, M.D
Family Medicine — Payments: $6,623
Family Medicine $6,623
Ms. Lauren Vigna, M.d, M.D
Family Medicine — Payments: $6,358
Family Medicine $6,358